{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-276426","form_type":"8-K","ticker":"HURA","cik":"0001498382","company_name":"TuHURA Biosciences, Inc./NV","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.598426+00:00","generated_at":"2026-05-29T04:01:26.030397+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"TuHURA to acquire Kineta in stock/cash merger; $35M concurrent financing required","bullets":["Consideration per Kineta share: initial stock based on $15M pool, delayed stock based on $5M, plus cash and contingent asset payment rights.","Closing requires TuHURA to raise at least $35M net proceeds from a concurrent private investment.","TuHURA will loan Kineta up to $900k at 5% interest to fund R&D expenses, secured by program assets.","Key conditions: stockholder approvals (Kineta merger vote; TuHURA authorized share increase to 200M), listing, and no law/order preventing deal.","Termination fee of $1M payable by Kineta if it accepts a superior proposal; $1M by TuHURA if it fails to close the concurrent investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-276426","json":"https://secwatch.observer/filing/0001193125-24-276426.json","markdown":"https://secwatch.observer/filing/0001193125-24-276426.md","text":"https://secwatch.observer/filing/0001193125-24-276426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/0001193125-24-276426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1498382/000119312524276426/d881353d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:01:26.030397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}